Page 16 - John Lambert News Today

Amplia Therapeutics Ltd (ASX:ATX) is poised to begin the recruiting for a Phase 2 clinical trial concerning its Focal Adhesion Kinase (FAK) inhibitor,...

Amplia Therapeutics Ltd (ASX:ATX)s Dr John Lambert discusses with Proactive a positive outcome from a pre-Investigational New Drug (pre-IND) meeting with...

"In my class of about 800 students, 18 were women and six were Black: five men and me."

Amplia Therapeutics Ltd (ASX:ATX) has begun pre-Investigational New Drug (pre-IND) interaction and discussion with the United States Food and Drug...

From cantatas to concertos, Michael White looks over the artist's ever-evolving musical voice

Amplia Therapeutics Ltd (ASX:ATX)s Dr John Lambert walks investors through the latest news on the companys AMP945 drug candidate, which just secured...

Online user that loves to ask employees about the weirdest questions they get revealed his collection of odd yet hilarious inquiries.

A Second World War veteran with dementia was forced out of his nursing home during the coronavirus pandemic when his money ran out after his local…

A Second World War veteran with dementia was forced out of his nursing home during the coronavirus pandemic when his money ran out after his local…

Dementia sufferer overpaid tens of thousands of pounds for care when Merton Council should have been contributing to fees